Solid Biosciences Inc.

NASDAQ: SLDB · Real-Time Price · USD
6.12
-0.05 (-0.81%)
At close: Aug 15, 2025, 3:59 PM
6.16
0.74%
After-hours: Aug 15, 2025, 07:15 PM EDT

Solid Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 3.12M n/a n/a n/a 4.74M n/a n/a n/a 8.09M n/a 6.17M 1.93M 3.15M 3.54M 3.59M 3.33M
Cost of Revenue
386K 407K 488K 405K 1.24M 327K 587K 588K 703K 1.08M 539K 438K 722K 709K 44.14M 14.43M 15.51M 14.21M
Gross Profit
-386K -407K -488K -405K -1.24M -327K -587K -588K -703K -1.08M 7.55M -438K 5.45M 1.22M -40.99M -10.89M -11.92M -10.87M
Operating Income
-41.69M -40.05M -39.9M -35.18M -27.79M -26.86M -22.27M -23.11M -26.84M -32.03M -28.91M -21.13M -25.38M -25.37M -18.65M -18.03M -18.68M -16.89M
Interest Income
2.97M 2.3M 1.93M 2.33M 2.56M 2.65M 1.66M 1.86M 2.06M 1.68M n/a 735K 293K n/a 64K n/a n/a n/a
Pretax Income
-39.48M -39.28M -42.6M -32.73M -25.07M -24.3M -20.34M -20.98M -24.63M -30.07M -15.15M -20.41M -25.09M -25.33M -18.61M -17.98M -18.7M -16.9M
Net Income
-39.48M -39.28M -42.6M -32.73M -25.07M -24.3M -20.34M -20.98M -24.63M -30.07M 4.6M -19.69M -24.8M -25.33M -18.61M -17.98M -18.7M -16.9M
Selling & General & Admin
9.28M 9.14M 9.13M 7.86M 8.33M 7.99M 6.22M 6.41M 7.13M 7.4M 7.62M 7.13M 6.85M 7.35M 7.21M 7.14M 6.77M 6.01M
Research & Development
32.41M 30.91M 30.77M 27.33M 19.46M 18.87M 15.45M 16.7M 19.78M 24.63M 21.29M 14.01M 23.18M 19.95M 14.6M 14.43M 15.51M 14.21M
Other Expenses
-386K -407K -488K n/a n/a -327K n/a n/a 265K 282K 5.66M 722K 290K 44K -22K 48K 3K -14K
Operating Expenses
41.31M 39.65M 39.41M 35.18M 27.79M 26.54M 21.68M 23.11M 26.91M 32.03M 28.91M 21.13M 30.03M 27.3M 21.81M 21.57M 22.28M 20.22M
Interest Expense
60K 68K 75K 82K 88K 95K n/a n/a 111K n/a n/a n/a n/a n/a n/a n/a 13K 14K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a -587K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
41.69M 40.05M 39.9M 35.18M 27.79M 26.86M 22.27M 23.11M 26.91M 32.03M 28.91M 21.13M 30.03M 27.3M 21.81M 21.57M 22.28M 20.22M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -19.75M -722K -290K -44K -64K -1K 13K n/a
Shares Outstanding (Basic)
94.14M 66.34M 40.82M 41.44M 40.93M 38.16M 20.39M 20.06M 19.66M 19.57M 8.02M 7.53M 7.52M 7.51M 7.36M 7.48M 7.33M 5.95M
Shares Outstanding (Diluted)
94.14M 66.34M 40.82M 41.44M 40.93M 38.16M 20.39M 20.06M 19.66M 19.57M 8.02M 7.53M 7.52M 7.51M 7.49M 7.48M 7.49M 5.95M
EPS (Basic)
-0.42 -0.59 -1.04 -0.79 -0.61 -0.64 -1 -1.05 -1.25 -1.54 0.57 -2.61 -3.3 -3.37 -2.53 -2.4 -2.55 -2.85
EPS (Diluted)
-0.42 -0.59 -1.04 -0.79 -0.61 -0.64 -1 -1.05 -1.25 -1.54 0.57 -2.61 -3.3 -3.37 -2.49 -2.4 -2.5 -2.85
EBITDA
-41.69M -38.81M -42.03M -32.24M -23.75M -23.88M -21.68M -20.39M -23.82M -28.87M -28.37M -20.69M -23.14M -24.66M -17.89M -17.28M -17.97M -16.15M
EBIT
-39.42M -39.21M -42.52M -32.64M -24.98M -24.21M -22.27M -20.98M -24.63M -30.07M -24.04M -21.13M -23.86M -25.37M -18.65M -18.03M -18.68M -16.89M
Depreciation & Amortization
386K 407K 488K 405K 1.24M 327K 587K 588K 703K 1.08M 539K 438K 722K 709K 760K 752K 718K 734K